CME Group said total contract volume increased in Q1 2025 compared with the same period in the prior year, citing market uncertainty surrounding tariffs and Federal Reserve interest rate policy. The company said volume increased across all product lines: interest rates, equity indexes, foreign exchange, agricultural commodities, energy and metals.

1. 01

   CME Group said total contract volume increased in Q1 2025 compared with the same period in the prior year, citing market uncertainty surrounding tariffs and Federal Reserve interest rate policy. The company said volume increased across all product lines: interest rates, equity indexes, foreign exchange, agricultural commodities, energy and metals.

2. 02

   The company said average rate per contract decreased in Q1 2025 compared with the same period in the prior year, citing higher volume tier-based incentives and increased micro equity contract volume as primary factors. It added that a fee structure increase that went into effect on February 1, 2025 partially offset the decrease.

3. 03

   CME Group said operating expenses increased by $6.0 million in Q1 2025 compared with the same period in the prior year. The company cited license fees related to higher volume for certain equity products, salary increases and higher headcount in international locations, and technology support services costs related to the Google Cloud transformation project as factors in the increase.

4. 04

   The company said earnings from cash performance bond and guaranty fund contributions that are reinvested totaled $873.6 million in Q1 2025, down from $1,036.7 million in Q1 2024. It added that expenses related to the distribution of interest earned on collateral reinvestments to clearing firms decreased to $804.8 million from $967.4 million.

Key figures

Quarter ended March 31, 2025

Revenue

$1.6B

Operating income

$1.1B

Net income

$956M

EPS

$2.62

Operating cash flow

$1.1B

Analysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.